Benjamin RS - Search Results

1

Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.

Quintana RA, Banchs J, Gupta R, Lin HY, Raj SD, Conley A, Ravi V, Araujo D, Benjamin RS, Patel S, Vadhan-Raj S, Somaiah N. Quintana RA, et al. Among authors: benjamin rs. Sarcoma. 2017;2017:7495914. doi: 10.1155/2017/7495914. Epub 2017 Sep 26. Sarcoma. 2017. PMID: 29081684 Free PMC article.

2

Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum.

Benjamin RS, Chawla SP, Carrasco CH, Raymond AK, Murray JA, Armen T, Patel S, Wallace S, Ayala A, Papadopoulos NE, et al. Benjamin RS, et al. Ann Oncol. 1992 Apr;3 Suppl 2:S3-6. doi: 10.1093/annonc/3.suppl_2.s3. Ann Oncol. 1992. PMID: 1622860 Free article.

3

Standard and high dose chemotherapy for advanced soft tissue sarcomas.

Patel S, Benjamin RS. Patel S, et al. Among authors: benjamin rs. Ann Oncol. 1992 Apr;3 Suppl 2:S81-3. doi: 10.1093/annonc/3.suppl_2.s81. Ann Oncol. 1992. PMID: 1622875 Free article. Review.

4

Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation.

Jaffe N, Patel SR, Benjamin RS. Jaffe N, et al. Among authors: benjamin rs. Hematol Oncol Clin North Am. 1995 Aug;9(4):825-40. Hematol Oncol Clin North Am. 1995. PMID: 7490244 Review.

5

Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.

Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S. Broxmeyer HE, et al. Among authors: benjamin rs. Exp Hematol. 1994 Jan;22(1):100-2. Exp Hematol. 1994. PMID: 7506671

6

Primary extraskeletal osteosarcoma--experience with chemotherapy.

Patel SR, Benjamin RS. Patel SR, et al. Among authors: benjamin rs. J Natl Cancer Inst. 1995 Sep 6;87(17):1331-3. doi: 10.1093/jnci/87.17.1331-a. J Natl Cancer Inst. 1995. PMID: 7658488 No abstract available.

7

In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.

Vadhan-Raj S, Broxmeyer HE, Andreeff M, Bandres JC, Buescher ES, Benjamin RS, Papadopoulos NE, Burgess A, Patel S, Plager C, Hittelman WN, McAlister I, Garrison L, Williams DE. Vadhan-Raj S, et al. Among authors: benjamin rs. Blood. 1995 Sep 15;86(6):2098-105. Blood. 1995. PMID: 7662957 Free article. Clinical Trial.

8

Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.

Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S. Broxmeyer HE, et al. Among authors: benjamin rs. Exp Hematol. 1995 Apr;23(4):335-40. Exp Hematol. 1995. PMID: 7895781 Clinical Trial.

9

Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy.

Patel SR, Burgess MA, Papadopoulos NE, Linke KA, Benjamin RS. Patel SR, et al. Among authors: benjamin rs. Am J Clin Oncol. 1995 Apr;18(2):161-3. doi: 10.1097/00000421-199504000-00014. Am J Clin Oncol. 1995. PMID: 7900708

10

Myxoid liposarcoma. Experience with chemotherapy.

Patel SR, Burgess MA, Plager C, Papadopoulos NE, Linke KA, Benjamin RS. Patel SR, et al. Among authors: benjamin rs. Cancer. 1994 Aug 15;74(4):1265-9. doi: 10.1002/1097-0142(19940815)74:4<1265::aid-cncr2820740414>3.0.co;2-x. Cancer. 1994. PMID: 8055448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page